President Obama Plans to Nominate New Head of FDA

From DCAT Value Chain Insights (VCI)

By Regulatory News posted 09-16-2015 13:23


President Barack Obama has announced his intent to nominate Dr. Rob Califf as the next Commissioner of the US Food and Drug Administration (FDA). He would replace the FDA's Acting Commissioner Dr. Stephen Ostroff, who has been serving on an interim basis since April 2015, when he took over the FDA's chief role following the departure of former FDA Commissioner Dr. Margaret Hamburg, who left her post at the end of March 2015. Dr. Hamburg had served as FDA Commissioner since 2009. After leaving the FDA, she became the Foreign Secretary of the Institute of Medicine (IOM), the health arm of the National Academy of Sciences.

Dr. Califf is currently Deputy Commissioner for Medical Products and Tobacco at the FDA, a position he has held since March 2015. Dr. Califf has served in various capacities at the Duke University School of Medicine and the Duke University Medical Center between 1982 and 2015. At the Duke University School of Medicine, he served as Vice Chancellor, Director of the Duke Translational Medicine Institute, which he founded in 2006, and as Professor of Medicine. He also served as the Director of the Cardiac Care Unit at the Duke University Medical Center. He founded the Duke University Clinical Research Institute in 2006 and served as its Director. Dr. Califf also served on the Executive Committee of the Duke Health System.

He has served in a number professional organizations, including committees of the Institute of Medicine of the National Academies (IOM), the IOM Clinical Research Roundtable, the IOM Committee on Medication Errors, and the IOM Board on Health Sciences Policy. He served on the FDA’s Cardio renal Advisory Committee from 1996 to 2000 and on the FDA’s Science Board Working Group from 2007 to 2008. Dr. Califf received a B.S. and an M.D. from Duke University.

Source: The White House


Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT). 

Learn more and sign up to receive a complimentary subscription